filmov
tv
Merck KGaA CEO says Covid impact on growth will 'progressively fade away'
Показать описание
Merck KGaA Belén Garijo CEO discusses the German health care company's full-year 2021 earnings and the impact of the Russia-Ukraine war on the company's clinical trials in the region.
Merck KGaA CEO says Covid impact on growth will 'progressively fade away'
Demand for Covid Products to Remain High: Merck KGaA CEO
Covid mRNA Vaccines Are 'Watershed Moment,' Says Merck CEO
Merck KGaA CFO Says More Deals Likely Amid Covid Boom
Life Sciences Benefiting From Covid, Says Merck KGaA CFO
Merck KGaA CEO: Pandemic has been a wake-up call for many EU citizens, politicians
Could Be 15 Months Before We Have Vaccine: Merck KGaA CFO
Germany’s Merck Predicts Reduced Impact From Coronavirus
4d pharma says Merck KGaA and Pfizer cancer collaboration is 'big step forward'
Merck says their new COVID pill shows promising results
Merck Ready to Produce Hundreds of Millions of Doses of Covid-19 Vaccine
Organic sales growth 'quite a homogenous picture,' says Merck KgaA CFO
We were cautious during the pandemic, but our businesses performed well: Merck KGaA CEO
Johns Hopkins Health Policy Forum with Merck CEO Robert M. Davis - October 4, 2021
U.S.-China tensions are the biggest worry we have, Merck CEO says
Merck Shuts Down Covid Vaccine Program After Lackluster Data
Merck to help make J&J's vaccine, White House official says
COVID-19: Merck addresses scientific progress
LIVE: Reuters Newsmaker with Merck KGaA Chief Executive Officer Belen Garijo
Merck-CEO Oschmann: „Ich fürchte eine noch größere Gesundheitskrise als Covid-19“
Merck KGaA CEO Sees Healthy Growth in All Key Parameters for 2019
Johnson and Johnson will get help from Merck to produce COVID-19 vaccines
Merck ends development of two potential COVID-19 vaccines
Coronavirus vaccine: Merck will help produce Johnson & Johnson COVID-19 vaccine
Комментарии